PCR-amplification has been used to screen 75 isolates of the Burkholderia cepacia complex for the cblA pilin gene. PCR-amplified products of the correct size (664 bp) were cloned and sequenced and the sequences compared. Apart from in the control, epidemic cystic fibrosis (CF)-associated B. cepacia lineage we also identified, for the first time, cblA genes in a unique, non-CF clinical isolate from France and a plant (onion) pathogenic isolate from Italy. The sequence of the cblA gene amplified from the clinical isolate was more diverged from the epidemic lineage than that amplified from the onion pathogenic isolate. ß
Introduction
The Gram-negative bacterium Burkholderia cepacia is a plant pathogen commonly found in soil and water and on plant surfaces [1] . Recently, many strains not known to be pathogenic to plants have been classi¢ed within the species, which is now often referred to as a species complex [2] . B. cepacia is generally non-pathogenic for healthy humans but is an important, opportunistic pathogen causing devastating respiratory-tract infections in patients with cystic ¢brosis (CF) [3, 4] and in other vulnerable individuals [5] . Additionally, many B. cepacia complex bacteria possess commercially useful properties and have been used, or are proposed for use in agriculture as biocontrol agents and in the bioremediation of toxic agents [6, 7] . Current classi¢cation divides isolates, which have been identi¢ed as B. cepacia into ¢ve genomovars or discrete species, all of which may be isolated from clinical infection [2] . Diagnostic tests for the determination of B. cepacia complex genomovar status using systematic approaches are continually being developed [8] . Recently attempts have been made to correlate transmissibility of epidemic strains of B cepacia between CF patients with the presence of speci¢c genetic markers [9] . These studies have suggested that the presence of a speci¢c virulence trait, the cblA gene, encoding giant cable pili [10, 11] is the most speci¢c marker for such epidemic strains [9] particularly as possession of cblA still appears to be a rare feature for the B. cepacia complex [8, 12] . The cblA gene encodes the major subunit protein of the pilus from an epidemic B. cepacia strain highly transmissible among CF patients in both the UK and the USA [10, 11] . These giant cable pili are very large and tangled and bind speci¢cally to CF mucin and airway epithelial cells [13] , and might explain the increased transmissibility of these epidemic strains [11] .
In this investigation we have used PCR-ampli¢cation to screen a number of isolates of the B. cepacia complex for the cblA pilin gene and cloned and sequenced the PCRampli¢ed products. Apart from in the control epidemic B. cepacia lineage we also identi¢ed, for the ¢rst time, cblA genes in a unique non-CF clinical isolate from France and a plant (onion) pathogenic isolate from Italy. The sequence of the cblA gene ampli¢ed from the clinical isolate is more diverged from the epidemic lineage than that ampli¢ed from the onion pathogenic isolate.
Materials and methods

Bacterial strains, media, and plasmids
Bacterial strains of di¡erent Burkholderia spp. used in this study are described in Table 1 and were isolated on PCAT [14] , TB-T [15] or SMSA [16] de¢ned media at 28³C and grown for analysis on nutrient agar (Oxoid) at 28³C. All had fatty acid pro¢les typical of the Burkholderia genus and all gave a characteristic product in a Burkholderia-speci¢c PCR-ampli¢cation assay [17] (results not shown). Escherichia coli DH5a cells were grown aerobically at 37³C in LB medium. For solid medium, 1% (w/v) agar was added. Plasmid DNA was prepared from recombinant E. coli using the Qiaprep spin miniprep kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. General recombinant DNA techniques were performed as described by Sambrook et al. [18] .
PCR-ampli¢cation of the cblA pilin structural gene
Chromosomal DNA was prepared by emulsifying two colonies from an overnight culture of each isolate in 100 Wl 50 mM NaOH. The extracts were then boiled for 5 min to lyse the cells before cooling on ice and diluting with 900 Wl distilled water. Alternatively chromosomal DNA was isolated using a DNeasy tissue kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. The extracted DNA was ampli¢ed by PCR with primers complementary to sequences upstream of the translation site and downstream of the termination site of the prepilin gene of B. cepacia isolate BC7 [10] (GenBank accession number Q47123). The sense primer, 5P-CCAAAGGAC-TAACCCA-3P, corresponded to nucleotide (nt) 357 to 372, and the antisense primer, 5P-ACGCGATGTCCAT-CACA-3P, corresponded to nt 583 to 599. PCR mixtures (25 Wl) contained primers (0.025 pmol), genomic DNA (500 ng), deoxyribonucleotide triphosphates (200 WM), Taq polymerase (1.25 U; Promega, Madison, WI, USA), MgCl 2 (15 mM), and bu¡er as supplied by the manufacturer. Ampli¢cation was performed for 1 cycle of 2 min at 94³C, 35 cycles of 1 min at 94³C, 1 min at 60³C and 1 min at 72³C, with a ¢nal extension step at 72³C of 10 min. The PCR-ampli¢ed products were analysed by electrophoresis in TAE-bu¡ered 1% (w/v) agarose gels [18] and compared with dsDNA markers of known size in a 100-bp ladder (Promega, Madison, WI, USA). Gels were stained with ethidium bromide before photography. PCR-ampli¢ed products were ligated into pGEM-T Easy vector (Promega, Madison, WI, USA) according to the manufacturer's instructions and transformed into competent E. coli cells.
DNA sequencing and analysis
Sequences of the PCR-ampli¢ed products were obtained by the Sanger chain-termination method, using dye-terminator cycle sequencing with AmpliTaq DNA polymerase FS (ABI PRISM 377). Sequence analysis was performed using the Pileup and BLAST programs (version 8.1, University of Wisconsin Genetics Computer Group, Madison, WI, USA) [19, 20] and a phylogenetic tree was constructed using the CLUSTAL X program [21] and drawn using Treeview version 1.6.1. freeware.
Nucleotide sequence accession numbers
The CooA, CfaB, CotA genes encode respectively the major subunits of E. coli CS1, CFA (colonisation factor antigen)/1 and CS2 ¢mbriae and have the accession numbers Q47123, AAB30543 and Q47124. The TcfB gene is the second gene in a putative ¢mbrial operon of Salmonella typhimurium and has the accession number AB029403. The nucleotide sequences of the cblA genes of B. cepacia isolates CFBP 2228-94 and NCPPB 3025 have been submitted to GenBank under accession numbers AJ304454 and AJ304455 respectively.
Results and discussion
All of the 75 Burkholderia genus isolates shown in Table  1 were screened for the presence of the cblA gene. The Fig. 1 . PCR-ampli¢cation screen for the cblA gene in some representative Burkholderia spp. isolates. Lanes 1 and 9 contain the 100-bp ladder DNA and the arrow indicates the 500-bp marker dsDNA. Lanes 2^8 and lanes 10^15 (lower tier) contain respectively PCR-ampli¢ed products obtained using DNA templates from Burkholderia isolates A599, R3, RR8, CFBP 2228-94, GR34, NCPPB 3025, WR21P, ONH, NCPPB 1962, K14, RLL7, MU23 and 84SM, all of which are described in Table 1. production of a ca 664-bp product indicated the presence of the cblA gene. A representative gel of a typical screen is shown in Fig. 1 . Isolate J2315 and another genomovar III strain [22] , 18863, a Canadian CF-associated clinical isolate, both typical of the epidemic lineage, generated 664-bp products, the predicted amino acid sequence of which was identical to that of isolate BC7 (results not shown). Additionally PCR products of a similar size were ampli¢ed from CFBP 2228-94 and NCPPB 3025 DNA (Fig. 1, lanes   5 and 7 respectively) . Bright bands were also produced following ampli¢cation of template DNA from new environmental isolates, R3 and MU23 but these bands were of the incorrect size (Fig. 1, lanes 3 and 14 respectively) . None of the remaining isolates gave any product. All of the PCR products were cloned and sequenced for comparative purposes. Sequencing of the PCR products ampli¢ed from CFBP-2228-94 and NCPBB 3025 DNA revealed that the amino acid sequences of proteins, predicted from the nucleotide sequences, had respectively 68 and 78% identity with that of the epidemic lineage cblA gene of isolate BC7 (Fig. 2) . The two ampli¢cation products of incorrect sizes had no homology with the cblA gene sequence (results not shown). Previously the cblA gene has been detected in strains from the epidemic lineage [10, 11] and in three unique strains isolated from CF patients ( [9, 22, 23] respectively). Here we report the detection of the cblA gene in another unique strain CFBP 2228-94, a clinical isolate from France which may be the ¢rst non-CF isolate to be identi¢ed carrying the cblA gene. Previous comparisons of the unique Jackson MI isolate cblA gene with the epidemic lineage cblA gene, revealed 88% sequence identity [10, 11] . In this study the deduced amino acid sequence of the CFBP 2228-94 cblA gene product is more divergent in its sequence and more distantly related to the epidemic lineage than NCPPB 3025 (Figs. 2 and 3) . The detection of the cblA gene in NCPPB 3025 is the ¢rst description of the gene in a known plant (onion) pathogenic isolate, although it has been previously identi¢ed in four environmental B. cepacia isolates [12] . Onion pathogenicity of this isolate was checked regularly in an onion bulb scale maceration assay. Repetitive extragenic palindromic (REP) ¢ngerprinting of NCPPB 3025 showed that it did not cluster with other onion pathogenic isolates but 16S rDNA PCR-ampli¢cation analysis de¢ned it as being most similar to B. cepacia although possibly a distinct genomovar (results not shown). Interestingly as compared to the epidemic lineage the deduced amino acid sequence of the NCPPB 3025 cblA gene product is less divergent in its sequence than the clinical isolate, CFPB 2228-94 (Figs.  2 and 3) . The cblA gene appears to be restricted to the B. cepacia complex and as previously shown recently [22] was not detected in any other Burkholderia spp. in this study. However Clode et al. [9] reported that one strain of Burkholderia gladioli contains the cblA gene. The deduced amino acid sequences of the cblA peptides of all three isolates investigated here have signi¢cant homology with the E. coli CooA, CfaB, and CotA peptides and the S. typhimurium TcfB peptide [24, 25] (Figs. 2 and  3) . CooA, CfaB and CotA are respectively the major subunits of the CS1, CFA/1 and CS2 pili and tcfB is the second ORF in a putative ¢mbrial operon. The putative sequences of the three cblA peptides determined in this study have all of the key features of pilin major subunit peptides including a leader sequence typical of prokaryotic signal sequences, for export across the cytoplasmic membrane, with a cleavage site followed by an uncharged alanine residue (Fig. 2) . Large proportions of the residues were apolar or hydrophobic, the latter being essential for pilin subunit polymerisation. The N-terminal residues of the three peptides were the most conserved. This particular group of pili proteins has no or few cysteine residues, which is unusual for pilin peptides. The pilin major subunit peptides are encoded by the second gene within an operon of four genes, the gene order of which appears to be highly conserved [24] . This operon is only found in the typhi serovar of Salmonella spp. and is inserted within a pathogenicity island found in clinical Salmonella isolates [25] . S. typhimurium is the causative agent of the most severe form of salmonellosis, typhoid fever. Additionally the expression of the CS1, CS2, and CFA/1 pili occurs in enterotoxigenic E. coli strains. The ability of pili of this type to adhere to epithelial cells may enhance colonisation and host^bacterium interactions and in all three cases, including B. cepacia, might represent human virulence markers. Our and other [12] descriptions of the presence of the cblA gene in isolates other than the epidemic lineage of B. cepacia indicate that it may not be a speci¢c marker for epidemic strains. However this is not to suggest that these other isolates do not have the potential to be epidemic for humans. As suggested previously [8, 9] a combination of PCR screening protocols for identi¢cation should be used to in£uence management and infection control strategies for the cepacia-syndrome. It is not known if environmental isolates of B. cepacia have the capacity to transfer the cblA gene to other isolates. However there is considerable evidence that the pilus operon is a mobile genetic element. The G+C content of the pilus genes is lower than that of the surrounding genomic DNA [10] . In E. coli the CS1 gene cluster is bound by IS-related sequences, and the 3P-terminus of an IS3 element has been detected upstream of the CS2 gene cluster [24] . In S. typhimurium the tcf operon appears to be inserted into a pathogenicity island (PI). It is not known if B. cepacia has a PI but B. pseudomallei appears to [26] and if B. cepacia does it is likely that the cblA gene resides within it. This aspect of those isolates of B. cepacia containing the cblA gene is now under investigation. Fig. 3 . Tentative unrooted phylogenetic tree showing the relative relationships between the amino acid sequences of the CooA, CfaB and CotA peptides, representing respectively the major subunits of the CS1, CFA/1 and CS2 pili of E. coli, the tcfB ORF (TCFB) in a putative ¢mbrial operon of S. typhimurium and B. cepacia NCPPB (NCPPB) 3025, CFBP (CFBP) 2228-94 and BC7 cblA peptides. The tree was constructed using the CLUSTAL X program [21] . The bar equals 10% estimated substitutions calculated by the Kimura correction.
